
Biopharma layoffs aren't letting up
The Top Line
00:00
Impact of Federal Cuts on Biopharma Layoffs
This chapter examines the ongoing layoffs within the biopharma sector, linking them to federal cuts and regulations that heighten industry uncertainty. It features examples from Icon Therapeutics and 10X Genomics, discussing the potential long-term impact of these challenges.
Transcript
Play full episode